NC H75

Requires prescription drug advertisements in North Carolina to include the FDA approval date and the date the drug first became available for purchase in the United States

Mandates that for each listed side effect, advertisements must disclose clinical trial details: trial length, number of participants, and frequency of the side effect (as a number or percentage)

Applies to all regulated advertisements by manufacturers across television, radio, internet, and print media directed at North Carolina consumers

Covers both prescription drugs and biological products (including vaccines, blood products, therapeutic serums, and proteins)

Takes effect October 1, 2025 for advertisements published on or after that date